Literature DB >> 20581427

Quantifying the effects of promoting smokeless tobacco as a harm reduction strategy in the USA.

Adrienne B Mejia1, Pamela M Ling, Stanton A Glantz.   

Abstract

BACKGROUND: Snus (a form of smokeless tobacco) is less dangerous than cigarettes. Some health professionals argue that snus should be promoted as a component of a harm reduction strategy, while others oppose this approach. Major US tobacco companies (RJ Reynolds and Philip Morris) are marketing snus products as cigarette brand line extensions. The population effects of smokeless tobacco promotion will depend on the combined effects of changes in individual risk with population changes in tobacco use patterns.
OBJECTIVE: To quantitatively evaluate the health impact of smokeless tobacco promotion as part of a harm reduction strategy in the US.
METHODS: A Monte Carlo simulation of a decision tree model of tobacco initiation and use was used to estimate the health effects associated with five different patterns of increased smokeless tobacco use.
RESULTS: With cigarette smoking having a health effect of 100, the base case scenario (based on current US prevalence rates) yields a total health effect of 24.2 (5% to 95% interval 21.7 to 26.5) and the aggressive smokeless promotion (less cigarette use and increased smokeless, health-concerned smokers switching to snus, smokers in smokefree environments switching to snus) was associated with a health effect of 30.4 (5% to 95% interval 25.9 to 35.2). The anticipated health effects for additional scenarios with lower rates of smokeless uptake also overlapped with the base case.
CONCLUSIONS: Promoting smokeless tobacco as a safer alternative to cigarettes is unlikely to result in substantial health benefits at a population level.

Entities:  

Mesh:

Year:  2010        PMID: 20581427      PMCID: PMC3102305          DOI: 10.1136/tc.2009.031427

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  32 in total

1.  The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts.

Authors:  David T Levy; Elizabeth A Mumford; K Michael Cummings; Elizabeth A Gilpin; Gary Giovino; Andrew Hyland; David Sweanor; Kenneth E Warner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-12       Impact factor: 4.254

2.  Role of snus in initiation and cessation of tobacco smoking in Sweden.

Authors:  L M Ramström; J Foulds
Journal:  Tob Control       Date:  2006-06       Impact factor: 7.552

Review 3.  A systematic review of interventions for smokers who contact quitlines.

Authors:  Lindsay F Stead; Rafael Perera; Tim Lancaster
Journal:  Tob Control       Date:  2007-12       Impact factor: 7.552

4.  Should doctors advocate snus and other nicotine replacements? Yes.

Authors:  John Britton
Journal:  BMJ       Date:  2008-02-16

5.  Should doctors advocate snus and other nicotine replacements? No.

Authors:  Alexander W Macara
Journal:  BMJ       Date:  2008-02-16

6.  Trends in smokeless tobacco use among adults and adolescents in the United States.

Authors:  David E Nelson; Paul Mowery; Scott Tomar; Stephen Marcus; Gary Giovino; Luhua Zhao
Journal:  Am J Public Health       Date:  2006-03-29       Impact factor: 9.308

7.  Should Australia lift its ban on low nitrosamine smokeless tobacco products?

Authors:  Coral E Gartner; Wayne D Hall
Journal:  Med J Aust       Date:  2008-01-07       Impact factor: 7.738

8.  Monitoring polytobacco use among adolescents: do cigarette smokers use other forms of tobacco?

Authors:  Jennifer M Bombard; Valerie J Rock; Linda L Pederson; Kat J Asman
Journal:  Nicotine Tob Res       Date:  2008-11       Impact factor: 4.244

9.  Young adult smoking behavior: a national survey.

Authors:  Pamela M Ling; Torsten B Neilands; Stanton A Glantz
Journal:  Am J Prev Med       Date:  2009-03-06       Impact factor: 5.043

10.  The effect of support for action against the tobacco industry on smoking among young adults.

Authors:  Pamela M Ling; Torsten B Neilands; Stanton A Glantz
Journal:  Am J Public Health       Date:  2007-06-28       Impact factor: 9.308

View more
  45 in total

1.  The nature, scope, and development of the global tobacco control epistemic community.

Authors:  Hadii M Mamudu; Mariaelena Gonzalez; Stanton Glantz
Journal:  Am J Public Health       Date:  2011-09-22       Impact factor: 9.308

2.  Sweden SimSmoke: the effect of tobacco control policies on smoking and snus prevalence and attributable deaths.

Authors:  Aimee M Near; Kenneth Blackman; Laura M Currie; David T Levy
Journal:  Eur J Public Health       Date:  2013-11-27       Impact factor: 3.367

3.  The Effect of Comparatively-Framed versus Similarity-Framed E-Cigarette and Snus Print Ads on Young Adults' Ad and Product Perceptions.

Authors:  Smita C Banerjee; Kathryn Greene; Yuelin Li; Jamie S Ostroff
Journal:  Tob Regul Sci       Date:  2016-07

4.  Misleading conclusions from Altria researchers about population health effects of dual use.

Authors:  Stanton A Glantz; Pamela M Ling
Journal:  Nicotine Tob Res       Date:  2011-02-24       Impact factor: 4.244

5.  Dual use of smokeless tobacco or e-cigarettes with cigarettes and cessation.

Authors:  Sara Kalkhoran; Rachel A Grana; Torsten B Neilands; Pamela M Ling
Journal:  Am J Health Behav       Date:  2015-03

Review 6.  Non-cigarette tobacco and the lung.

Authors:  Michael Schivo; Mark V Avdalovic; Susan Murin
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

7.  A qualitative study of smokers' responses to messages discouraging dual tobacco product use.

Authors:  Lucy Popova; Ganna Kostygina; Nicolas M Sheon; Pamela M Ling
Journal:  Health Educ Res       Date:  2014-01-17

8.  Trends in use of electronic nicotine delivery systems by adolescents.

Authors:  Deepa R Camenga; Jennifer Delmerico; Grace Kong; Dana Cavallo; Andrew Hyland; K Michael Cummings; Suchitra Krishnan-Sarin
Journal:  Addict Behav       Date:  2013-09-17       Impact factor: 3.913

9.  "Smoking revolution": a content analysis of electronic cigarette retail websites.

Authors:  Rachel A Grana; Pamela M Ling
Journal:  Am J Prev Med       Date:  2014-04       Impact factor: 5.043

10.  Modeling the Health Effects of Expanding e-Cigarette Sales in the United States and United Kingdom: A Monte Carlo Analysis.

Authors:  Sara Kalkhoran; Stanton A Glantz
Journal:  JAMA Intern Med       Date:  2015-10       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.